Pfizer CEO Albert Bourla collects $27.6M in 2025 pay

Pfizer CEO Albert Bourla collects $27.6M in 2025 pay following Metsera, MFN deals Pfizer’s CEO, Albert Bourla, Ph.D., has yet to top the $33 million in compensation that he earned on the coattails of megablockbuster COVID-19 sales in 2022, but a $27.6 million pay package after a busy 2025 isn’t too shabby. Bourla’s 2025 rewards …

READ MORE

Astrazeneca and Pfizer accused of funding terrorism in Iraq

London, January 24, 2026, 19:48 GMT — Markets have closed A U.S. appeals court has revived a terrorism-funding lawsuit against AstraZeneca and several other companies linked to Iraq. AstraZeneca shares closed higher in New York on Friday and edged up in London; the ruling was announced after U.S. markets closed Investors will be eyeing Monday’s …

READ MORE

Pfizer quietly pays $530M for vaccine booster tech.

Pfizer has signed a deal worth up to $530m with US-based vaccine technology company Novavax. This agreement will see Pfizer hand over $30m upfront for the non-exclusive rights to Novavax’s proprietary Matrix-M vaccine adjuvant, which is designed to boost and prolong the immune response when added to an injectable formulation. Pfizer will be wholly responsible …

READ MORE

Pfizer has so far fired nearly 2000 people in cost cutting

Pfizer is in the midst of an aggressive, multi-year cost-cutting effort, which so far has left nearly 2,000 people jobless. Pfizer will part ways with more than 200 employees across Switzerland as part of continuing effort to slow its cash burn, according to a Wednesday report from Bloomberg. After the layoffs, the pharma expects its …

READ MORE

Pfizer buys Metsera for $10 Billion.

Pfizer beats out Novo with $10B agreement to buy Metsera After a chaotic and fierce bidding clash that only burst out into public view a little more than a week ago, Pfizer has prevailed in its pursuit of obesity biotech Metsera. https://www.fiercebiotech.com/biotech/pfizer-beats-out-novo-10b-agreement-buy-metsera Bourla claims his new products are moving at the “speed of light.” Full… …

READ MORE

Bourla’s Pfizer bought cancer company Seagen for $43B while baffled researchers contend with massive uptick in cancer in young folk…

Perplexed! 🤣 “But while researchers are still working to better understand what could be driving the perplexing rise,” It’s a good thing Pfizer bought cancer company Seagen for $43 billion to take advantage of the trend🥴. https://t.co/oegNTGW5GM — Edward Dowd (@DowdEdward) October 27, 2025 And just think, these cancer rates were in a solid multi-decade …

READ MORE

Pfizer Nears $7.3B Purchase of Anti-Obesity Drugmaker Metsera

https://invezz.com/news/2025/09/22/pfizer-close-to-acquiring-metsera-for-7-3b-targeting-breakthrough-obesity-drug/ Pfizer nears $7.3B deal to acquire Metsera, targeting next-gen obesity treatments. MET-097i shows 11.3% weight loss in trials and offers monthly dosing. Acquisition positions Pfizer against Novo Nordisk and Eli Lilly in obesity market. Pfizer is making a bold move in the pharmaceutical world by closing in on a $7.3 billion deal to acquire …

READ MORE

The CEO of Pfizer is demanding Donald Trump be given the nobel Peace prize for the COVID vaccine, and Republicans agree

Pfizer CEO says Trump "worthy of Nobel Peace Prize" for COVID vaccines https://t.co/Mmt2ARKBHe — Axios (@axios) September 3, 2025 Sen. Bill Cassidy and Pfizer CEO say Trump is worthy of a Nobel prize for the COVID vaccine https://t.co/qlRAvmOKTE — The Hill (@thehill) September 3, 2025 Sen. Bill Cassidy (R-La.) and Pfizer CEO Albert Bourla on …

READ MORE

RFK, Jr.’s FDA has approved the updated Pfizer mRNA COVID shots, will begin shipping immediately

U.S. regulators approved Pfizer’s updated COVID-19 shot Wednesday. U.S. health officials did not immediately confirm the news but they generally approve updated shots from the nation’s two leading COVID-19 vaccine makers at the same time. Moderna did not immediately respond to requests for comment. This year’s updated vaccines target a newer version of the continuously …

READ MORE

Pfizer bribery probe dropped after ex-company lawyer Pam Bondi takes over DOJ in February 2025.

The DOJ dropped its Pfizer bribery probe in China and Mexico soon after Pam Bondi, a former Pfizer legal consultant, became Attorney General in February 2025. The investigation’s closure, evident from Pfizer’s latest filings, has raised concerns about Bondi’s influence and DOJ impartiality. The DOJ dropped its Pfizer bribery investigation soon after Pam Bondi, a …

READ MORE

Pfizer and Flynn Pharma fined £69 million for charging excessive prices on epilepsy drugs

Pfizer and Flynn Pharma, manufacturers of phenytoin sodium capsules which are used to treat epilepsy, have been fined a combined total of £69 million by the Competitions Appeal Tribunal (CAT) for “charging excessive prices” between 2012 and 2016. Around 48,000 people with epilepsy in the UK depend on the drugs supplied by Flynn Pharma and …

READ MORE

Pfizer Voluntarily Withdraws All Lots of Sickle Cell Disease Treatment From Worldwide Markets

NEW YORK–(BUSINESS WIRE)– Pfizer Inc. (NYSE: PFE) announced today that it is voluntarily withdrawing all lots of OXBRYTA ® (voxelotor) for the treatment of sickle cell disease (SCD) at this time, in all markets where it is approved. Pfizer is also discontinuing all active voxelotor clinical trials and expanded access programs worldwide. Pfizer’s decision is based on the …

READ MORE

Pfizer CEO Albert Bourla has just received the AACR Outstanding Achievement Award for Service to Cancer Science and Medicine

Albert Bourla, PhD, Chairman and Chief Executive Officer of Pfizer Inc., accepts the AACR Outstanding Achievement Award for Service to Cancer Science and Medicine from @AACRPres Philip D. Greenberg and @AACR_CEO Margaret Foti to close the #AACR24 Opening Ceremony. pic.twitter.com/rSMBxiorA5 — AACR (@AACR) April 7, 2024 Outstanding Achievement Award for Service to Cancer Science and …

READ MORE

Pfizer Buys Company That Treats Turbo Cancer

Pfizer’s $43B cancer drug acquisition raises suspicion. CEO’s statements hint at broader, ominous implications beyond finance. NEW ARTICLE: Pfizer completes $43 Billion acquisition of Seagen on Dec.14, 2023 – becomes largest oncology company to treat most TURBO CANCERS caused by mRNA Vaccines – deep dive into the sinister aspects of this very bizarre deal. Pfizer …

READ MORE

Puts on Pfizer?

IP law has gotten out of hand. Protections are too long and granted on the most minor of changes to existing generic drugs. h/t McBooples

Pfizer to shut 2 plants

The company told multiple local media outlets that it would be closing its sites in Durham and Morrisville, saying the closures are part of an effort “to operate more efficiently and effectively.” “As part of this effort, Pfizer has decided to close the Kit Creek facility in Morrisville … and the Durham Clinical Manufacturing Facility,” …

READ MORE

Pfizer To Lay Off Hundreds As Covid Revenue Falls

GLADSTONE, NJ —Massive layoffs will soon be underway as Pfizer will be cutting nearly 800 people from its Gladstone location in the coming new year. Pfizer will lay off 791 employees on Feb. 12, 2024, from its Somerset County corporate office, according to a Worker Adjustment and Retraining Notification(WARN) Notice shared by the New Jersey …

READ MORE

Pfizer building destroyed by tornado

Pfizer building was destroyed today by tornado about 40 minutes from where I live. It happened in Rocky Mount, NC. 50,000 pallets of medicine destroyed. I wonder if any of it had MRNA as an ingredient? pic.twitter.com/jSORI7l8PX — ⚔Dennis⚔ (@clovis1931) July 19, 2023

Pfizer expects to run out of antibiotic supply soon

Pfizer will run out of several doses of penicillin, which treat syphilis, strep throat, and other infections, later this year as shortages ripple across the US supply chain. The company anticipates running out of the children’s dose of the syphilis drug Bicillin L-A by the end of June, according to a letter Pfizer posted Tuesday …

READ MORE

Uh-oh! It looks like you're using an ad blocker.

Our website relies on ads and the generous support of readers like you to keep delivering free, high-quality content. Right now, we are facing serious funding challenges and we need your help more than ever. Disable your ad blocker and this message will vanish. You can also sign up for a membership to enjoy an ad-free experience while supporting our work: https://citizenwatchreport.com/plans/subscriptions/ Your support helps us stay independent, continue our work, and keep content free for everyone. We truly appreciate your understanding and thank you for standing with us.